All In MedTech

Device Trial Radar · NCT03883217

Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Last checked: Nov 20, 2026Latest source record: Mar 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

12

Actual

Start

Jun 29, 2021

Primary completion

Jan 11, 2022

Study completion Jan 11, 2022

Sponsor

Lead sponsor
Virginia Commonwealth UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Michael J. Fox Foundation for Parkinson's Research
First posted
Mar 20, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 95 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to test the safety, tolerability, and the effect of vibration (delivered by an experimental device called PDVibe2) on freezing of gait (FOG) in persons with Parkinson's disease (PD). The PDVibe2 was developed by Resonate Forward, LLC (RF). This PDVibe2 was designed to administer vibration therapy to the wearer to improve gait and balance in persons with PD while wearing the device.

Conditions

  • Parkinson Disease

Interventions

  • Vibration SessionDevice

    The PDVibe2 is owned by Resonate Forward, LLC and will be loaned to Virginia Commonwealth University (VCU) for this project. The device is non-invasive, lightweight, untethered, contains a rechargeable battery, and is worn on both feet and ankles. PDVibe2 delivers vibration when activated by an easy to access switch on the device or by remote. The internal circuitry has been miniaturized, is encased in a small box, and is attached to the ankle using a soft flexible band.

  • No vibration sessionDevice

    The PDVibe2 is owned by Resonate Forward, LLC and will be loaned to Virginia Commonwealth University (VCU) for this project. The device is non-invasive, lightweight, untethered, contains a rechargeable battery, and is worn on both feet and ankles. During this session, PDVibe2 delivers no vibration but is still worn. The internal circuitry has been miniaturized, is encased in a small box, and is attached to the ankle using a soft flexible band.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Functional Ambulation Profile (FAP) ScoreTime frame: Throughout study completion, from 9 to 34 days.
  2. Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)Time frame: Throughout study completion, from 9 to 34 days.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Virginia Commonwealth University

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.